In the News
World's Biggest Players in Pharma
10th July 2017
If you are looking for a good example of economies of scale and a global oligopoly then pharmaceuticals fits the bill. Here is a snazzy infographic showing global prescription sales and research and development spending.
During 2016, world market leader Pfizer's prescription sales were approximately 45.9 billion US dollars, while R&D spending was approximately 7.8 billion dollars.
Geoff Riley
Geoff Riley FRSA has been teaching Economics for over thirty years. He has over twenty years experience as Head of Economics at leading schools. He writes extensively and is a contributor and presenter on CPD conferences in the UK and overseas.
You might also like
UK Manufacturing - Supply Chains Need Strengthening
9th November 2014
Research & Development & New Products
Study Notes
China Enters the Global Aircraft Engine Market
30th August 2016
How to grow a business idea
11th December 2016
Dyson plugging the skills gap
15th February 2017
Government and business in partnership to beat Alzheimer's
20th June 2017
Inside Microsoft's AI research labs
9th July 2017